Last 23rd of may, Jordi Mill was invited to "la Xarxa" to talk about VIDAA, a platform developed in UPF with the collaboration of Hospital Clínic de Barcelona and Hospital de la Santa Creu i Sant Pau. VIDAA allows clinicians to select the most appropiate Left Atrial Appendage Occulder (LAAO) device configuration and enables the performace of in-silico clinical studies on virtual populations. Follow the link to see the interview.